ZTNA
GILD icon

Zions Trust National Association’s Gilead Sciences GILD Stock Holding History

Zions Trust National Association’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-300
Closed -$25K – 227
2014
Q2 		$25K Buy
+300
New +$23.4K 0.04% 132

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Zions Trust National Association's GILD Position: Q3 2014 in Review

Zions Trust National Association sold out of Gilead Sciences (GILD) in Q3 2014, closing a stake of 300 shares — an estimated $25K sold.

Zions Trust National Association first reported a position in GILD in Q2 2014 and held it in 1 quarter. The position peaked at $25K in Q2 2014. 1,327 funds tracked by Wall St. Rank hold GILD as of Q3 2014.

  • Zions Trust National Association reported no remaining Gilead Sciences position as of Q3 2014 after selling out during the quarter.
  • Zions Trust National Association sold 300 Gilead Sciences shares in Q3 2014, an estimated $25K.
  • Zions Trust National Association first reported a position in Gilead Sciences in Q2 2014 and held it in 1 quarter.
  • Zions Trust National Association's Gilead Sciences position peaked at $25K in Q2 2014.
  • 1,327 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2014.

Based on Zions Trust National Association's 13F filing for Q3 2014, filed 16 Oct 2014.